o-Propionotoluidide, 2-(propylamino)-; BRN 2108498; N-(2-Methylphenyl)-2-(propylamino)propanamide; DivK1c_000846; o-Methyl-2-propylaminopropionanilide; (S)-N-(2-Methylphenyl)-2-(propylamino)propanamide; o-Propionotoluidide, 2- (propylamino)-; Prilocainum [INN-Latin]; D00553; Citanest.
show more »
o-Propionotoluidide, 2-(propylamino)-; BRN 2108498; N-(2-Methylphenyl)-2-(propylamino)propanamide; DivK1c_000846; o-Methyl-2-propylaminopropionanilide; (S)-N-(2-Methylphenyl)-2-(propylamino)propanamide; o-Propionotoluidide, 2- (propylamino)-; Prilocainum [INN-Latin]; D00553; Citanest; NSC40027; (R)-N-(2-Methylphenyl)-2-(propylamino)propanamide; Emla Cream; Spectrum3_001052; KBio2_007265; 2-Methyl-alpha-propylaminopropionanilide; C07531; o-Methyl-alpha-propylaminopropionanilide; KBioGR_001883; Oraqix; o-Propionotoluidide, 2-propylamino-; Astra 1515; 14289-31-7; Astra 1512; Prestwick1_000199; Propanamide, N-(2-methylphenyl)-2-(propylamino)-, (S)-; Prilocaina [INN-Spanish]; 721-50-6; Propanamide, N- (2-methylphenyl)-2-(propylamino)-; L 67; HSDB 3386; SPBio_002078; Prilocaine (USP); Spectrum4_001192; EINECS 211-957-0; Spectrum2_001549; Prilocaine; KBio3_001824; SPBio_001398; KBio2_004697; 2-Methyl-.alpha.-propylaminopropionanilide; Prilocaine [USAN]; Spectrum_001649; NSC 40027; alpha-n-Propylamino-2-methylpropionanilide; NINDS_000846; 14289-32-8; Propanamide, N-(2-methylphenyl)-2-(propylamino)-; Prestwick0_000199; KBio2_002129; Propanamide, N-(2-methylphenyl)-2-(propylamino)-, (R)-; o-Propionotuluidide, 2-propylamino-; KBio1_000846; KBioSS_002129; Propitocaine; Propanamide, N-(2-methylphenyl)-2-(propylamino)- (9CI)
show less «